Drystone’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Drystone's PFE Position: Q2 2026 in Review
Drystone increased its Pfizer (PFE) stake by 0.08% in Q2 2026, buying an estimated $3.53K and bringing the position to 165,789 shares worth $3.99M. The position accounts for 3.28% of the portfolio, ranked #12.
Drystone first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.65M in Q1 2026. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Drystone held 165,789 shares of Pfizer worth $3.99M as of Q2 2026.
- Drystone bought 135 Pfizer shares in Q2 2026, an estimated $3.53K.
- Pfizer made up 3.28% of Drystone's portfolio in Q2 2026, its #12 holding.
- Drystone first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
- Drystone's Pfizer position peaked at $4.65M in Q1 2026.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Drystone's 13F filing for Q2 2026, filed 24 Jul 2026.